Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects

Overview of attention for article published in Drug Design, Development and Therapy, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the…

Grant US-11787782-B2

United States of America

Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan

Grant US-11680058-B2

United States of America

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the…

Grant US-11174247-B2

United States of America

COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGREDIENTS FOR THE…

Application US-20200061061-A1

United States of America